356 Studies Now Enrolling
A Randomized Controlled Trial Examining Extended-Release Injectable Buprenorphine in those who use High Potency Synthetic Opioids
A Clinical Trial Comparing Buprenorphine Medications for people who use Fentanyl and/or other High Potency Synthetic Opioid Use
| Sponsor: | National Institute on Drug Abuse |
| Enrolling: | Male and Female Patients |
| Study Length: | 12 Weeks |
| Clinic Visits: | 12 |
| IRB Number: | AAAV2503 |
| U.S. Govt. ID: | NCT06726200 |
| Contact: | Rachel Luba: 646-774-8189 / rrl2117@cumc.columbia.edu |
Additional Study Information:
Columbia University Medical Center is recruiting individuals ages 18-65 who are seeking treatment for opioid use disorder to participate in a research treatment study. For your participation, you'll receive treatment with buprenorphine (either sublingual or injectable) at no cost. Participants will complete an overnight inpatient stay to start buprenorphine and then return for follow up visits. Participants will be compensated up to $540 for completion of all screening and follow up visits.
